BACKGROUND: We hypothesize that functional control of the serotonergic system is regulated in part by differential expression of the serotonin (5-HT) transporter (5-HTT). Alcohol-dependent individuals with the LL/LS genotype (L-carriers), compared with those with the SS genotype, have a lower 5-HT neurotransmission, which we hypothesize would be associated with higher craving for alcohol among L-carriers. We hypothesize further that acute peripheral depletion of tryptophan (5-HT's precursor), while further reducing 5-HT function, might decrease auto-inhibition of 5-HT neuronal firing, thereby increasing 5-HT neurotransmission transiently and lowering alcohol craving. METHODS: We tested these hypotheses by examining whether in 34 Hispanic alcohol-dependent individuals subjective and physiological cue craving for alcohol differed by genotype, age of onset of problem drinking, and tryptophan availability. RESULTS: On subjective "urge to drink" and "crave for a drink," we found a significant (p < 0.05) main effect of genotype and cue, as well as an interaction among genotype, age of onset of problem drinking, and tryptophan depletion. For the physiological measure of pulse, there was a main effect of genotype. L-carriers had higher craving than their SS counterparts, an effect that decreased under tryptophan depletion. While craving in L-carriers increased with an earlier age of onset of problem drinking, the opposite effect was seen in those with the SS genotype. CONCLUSION: These results not only provide support for the hypothesis that alcoholics who are L-carriers have greater alcohol craving and possibly greater propensity for drinking but also propose that there is an important 5-HTT gene-by-environment interaction that alters cue craving response for alcohol.
BACKGROUND: We hypothesize that functional control of the serotonergic system is regulated in part by differential expression of the serotonin (5-HT) transporter (5-HTT). Alcohol-dependent individuals with the LL/LS genotype (L-carriers), compared with those with the SS genotype, have a lower 5-HT neurotransmission, which we hypothesize would be associated with higher craving for alcohol among L-carriers. We hypothesize further that acute peripheral depletion of tryptophan (5-HT's precursor), while further reducing 5-HT function, might decrease auto-inhibition of 5-HT neuronal firing, thereby increasing 5-HT neurotransmission transiently and lowering alcohol craving. METHODS: We tested these hypotheses by examining whether in 34 Hispanic alcohol-dependent individuals subjective and physiological cue craving for alcohol differed by genotype, age of onset of problem drinking, and tryptophan availability. RESULTS: On subjective "urge to drink" and "crave for a drink," we found a significant (p < 0.05) main effect of genotype and cue, as well as an interaction among genotype, age of onset of problem drinking, and tryptophan depletion. For the physiological measure of pulse, there was a main effect of genotype. L-carriers had higher craving than their SS counterparts, an effect that decreased under tryptophan depletion. While craving in L-carriers increased with an earlier age of onset of problem drinking, the opposite effect was seen in those with the SS genotype. CONCLUSION: These results not only provide support for the hypothesis that alcoholics who are L-carriers have greater alcohol craving and possibly greater propensity for drinking but also propose that there is an important 5-HTT gene-by-environment interaction that alters cue craving response for alcohol.
Authors: A Heinz; D W Jones; C Mazzanti; D Goldman; P Ragan; D Hommer; M Linnoila; D R Weinberger Journal: Biol Psychiatry Date: 2000-04-01 Impact factor: 13.382
Authors: W H Kaye; K A Gendall; M H Fernstrom; J D Fernstrom; C W McConaha; T E Weltzin Journal: Biol Psychiatry Date: 2000-01-15 Impact factor: 13.382
Authors: Ronald M Salomon; John S Kennedy; Benjamin W Johnson; Dennis E Schmidt; Joseph Kwentus; Harry E Gwirtsman; Michael H Ebert Journal: Neuropsychopharmacology Date: 2003-03-19 Impact factor: 7.853
Authors: Ismene L Petrakis; Stephanie O'Malley; Bruce Rounsaville; James Poling; Colette McHugh-Strong; John H Krystal Journal: Psychopharmacology (Berl) Date: 2003-11-21 Impact factor: 4.530
Authors: Amira Pierucci-Lagha; Richard Feinn; Vania Modesto-Lowe; Robert Swift; Maggie Nellissery; Jonathan Covault; Henry R Kranzler Journal: Psychopharmacology (Berl) Date: 2003-09-10 Impact factor: 4.530
Authors: Rachel D Thompson; Jaimee L Heffner; Judith A Strong; Thomas J Blom; Robert M Anthenelli Journal: Alcohol Date: 2010-07-03 Impact factor: 2.405
Authors: Chong-Bin Zhu; Kathryn M Lindler; Anthony W Owens; Lynette C Daws; Randy D Blakely; William A Hewlett Journal: Neuropsychopharmacology Date: 2010-09-08 Impact factor: 7.853
Authors: Bankole A Johnson; Nassima Ait-Daoud; Chamindi Seneviratne; John D Roache; Martin A Javors; Xin-Qun Wang; Lei Liu; J Kim Penberthy; Carlo C DiClemente; Ming D Li Journal: Am J Psychiatry Date: 2011-01-19 Impact factor: 18.112
Authors: Michael A Dawes; John D Roache; Martin A Javors; Susan E Bergeson; Dawn M Richard; Charles W Mathias; Nassima Ait-Daoud; Donald M Dougherty; Bankole A Johnson Journal: J Stud Alcohol Drugs Date: 2009-11 Impact factor: 2.582
Authors: Nassima Ait-Daoud; Chamindi Seneviratne; Justin B Smith; John D Roache; Michael A Dawes; Lei Liu; Xin-Qun Wang; Bankole A Johnson Journal: Front Psychiatry Date: 2012-02-16 Impact factor: 4.157
Authors: George A Kenna; Nick Roder-Hanna; Lorenzo Leggio; William H Zywiak; James Clifford; Steven Edwards; John A Kenna; Jessica Shoaff; Robert M Swift Journal: Pharmgenomics Pers Med Date: 2012-01-13